title: [Intravenous immunoglobulins in chronic idiopathic myositis].
authors.affiliation: Rheumaklinik für Kinder und Jugendliche, Gehfeldstr. 24, 82467 Garmisch-Partenkirchen, Germany. michels.hartmut@rummelsberger.net
authors.forename: H
authors.initials: H
authors.lastname: Michels
authors.forename: G-R
authors.initials: GR
authors.lastname: Burmester
authors.forename: F
authors.initials: F
authors.lastname: Buttgereit
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D000075202:Contraindications; D003882:Dermatomyositis / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007116:Immunization, Passive / Q000009:adverse effects; D007074:Immunoglobulin G / Q000008:administration & dosage* / Q000009:adverse effects; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D007262:Infusions, Intravenous; D008875:Middle Aged; D018979:Myositis, Inclusion Body / Q000188:drug therapy* / Q000276:immunology; D017285:Polymyositis / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome
chemical_list: C021306:IgG, sulfonated; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents